🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to test whether vaccination with HAVpur Junior against hepa...
Status
Completed
Location
Medical College and Chacha Nehru Bal Chikitsalay
Start Date
2010-03
Trial ID
NCT01349829
Treatments Being Tested
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
This study is to evaluate the safety, tolerability and immunogenicity of a ...
Status
Completed
Location
Daido Clinic
Start Date
2018-07-12
Trial ID
NCT03571607
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
It is probable that a mucosal approach is necessary for a prophylactic HIV ...
Status
Terminated
Location
Hopital Tenon
Start Date
2003-06
Trial ID
NCT00122564
Treatments Being Tested
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
A phase 3, randomized, double-blind trial to evaluate the safety and immuno...
Status
Completed
Location
Seishinkai Inoue Hospital
Start Date
2021-06-14
Trial ID
NCT04875533
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009